Two distinct human endothelin B receptors generated by alternative splicing from a single gene

Area of Science:

• Molecular Biology
• Genetics
• Receptor Biology

Background:

• The endothelin B receptor (ETB) plays a crucial role in various physiological processes.
• Understanding receptor variants is essential for comprehending human physiology and disease.
• Alternative RNA splicing is a known mechanism for generating protein diversity.

Purpose of the Study:

• To identify and characterize novel variants of the endothelin B receptor (ETB) in human tissues.
• To investigate the genetic origin and expression of a newly discovered ETB variant.
• To analyze the structural and functional implications of the ETB1 variant.

Main Methods:

• Reverse transcriptase polymerase chain reaction (RT-PCR) to detect ETB variants in human tissues.
• Polymerase chain reaction (PCR) on genomic DNA to analyze gene structure.
• Southern blot analysis for chromosomal DNA.
• Heterologous expression systems to study ligand binding and functional properties of ETB and ETB1.

Main Results:

• A novel ETB variant, termed ETB1, was identified in human brain, placenta, lung, and heart.
• ETB1 contains an additional 30-nucleotide sequence, resulting in a 10 amino acid increase in the second cytoplasmic domain.
• Genomic analysis confirmed ETB1 arises from alternative RNA splicing of the human ETB gene, with the insert sequence being human-specific.

Conclusions:

• A novel human-specific ETB variant (ETB1) is generated through alternative RNA splicing.
• The ETB1 variant exhibits stable expression and possesses distinct structural features compared to the canonical ETB receptor.
• Further studies are warranted to elucidate the specific functional roles and potential implications of the ETB1 variant in human physiology.